Content about Generics

December 1, 2011
Senators look into Pfizer-PBM deal for Lipitor

Pfizer's efforts to protect the sales of its blockbuster cholesterol drug Lipitor have attracted scrutiny from members of Congress, according to published reports.

December 1, 2011
Warner Chilcott sues Mylan, Famy Care over Generess Fe patent challenge

Generic drug maker Mylan and a partnering company are challenging the patent on a contraceptive drug.

November 30, 2011
Packaged Facts: Pet drug sales to reach $6.7 billion in 2011

While sales figures for pharmaceuticals are frequently reported on, drugs for people's four-legged friends also are a money maker.

November 30, 2011
Ranbaxy generic Lipitor launch delayed as Watson launches authorized generic

Ranbaxy Labs was supposed to launch its generic version of the world's top-selling drug Wednesday, but a competitor beat it to the punch as the former waits for final Food and Drug Administration clearance.

November 29, 2011
Qualitest receives FDA approval for Myzilra tablets

The Food and Drug Administration has approved a new oral contraceptive manufactured by Endo subsidiary Qualitest Pharmaceuticals.

November 29, 2011
Taro board member steps down

Taro Pharmaceutical Industries announced that one of its board members has resigned.

November 29, 2011
Watson gets green light for generic Yaz

Watson Pharmaceuticals subsidiary Watson Labs has received regulatory approval for a generic oral contraceptive.

November 28, 2011
FDA approves Mylan chemoprotective agent

The Food and Drug Administration has approved a generic drug made by Mylan for cancer patients.

November 23, 2011
FDA approves first drug for insomnia with middle-of-night waking, difficulty returning to sleep

The Food and Drug Administration has approved the first drug for insomnia in which patients wake in the middle of the night and have trouble returning to sleep.

November 23, 2011
Pfizer to sell Lipitor directly by mail

Pfizer is looking to sell its top-selling cholesterol drug directly to consumers at a greatly reduced price after the patent expires, according to published reports.

November 22, 2011
Par appoints new president, COO

Generic drug maker Par Pharmaceutical has promoted Thomas Haughey to president and Paul Campanelli to COO, the company said. The promotions take effect immediately.

November 21, 2011
Aceto launches generic drugs for infections, malaria

A subsidiary of Aceto Corp. has launched two generic drugs for treating infectious diseases, the company said Monday.

November 21, 2011
Impax Labs looks to market generic cancer pain drug

Drug maker Impax Labs is looking to challenge the patent protection on a drug used to treat pain related to cancer, the company said Monday.

November 21, 2011
Mylan granted license to market generic menopause drug

Mylan will begin selling a generic drug for treating symptoms of menopause in two years, the company said Monday.

November 21, 2011
Perrigo names M&A vet to corporate development post

Perrigo on Monday named Christopher Roop to the post of VP corporate development.

November 18, 2011
Citi: Flu season to peak later in 2012 than it did last year

Citi Investment Research & Analysis is projecting that the peak of flu season may occur beyond last season's peak of January/February, a factor that may place a negative drag on retail same-store sales results over first quarter 2012.

November 18, 2011
Par completes acquisition of Anchen

Par Pharmaceutical has completed its acquisition of Anchen Pharmaceuticals, the generic drug maker said.

November 16, 2011
Report: Pfizer seeks aid of PBMs in efforts to block generic versions of Lipitor

When its blockbuster cholesterol drug Lipitor loses patent protection this month, Pfizer is hoping that pharmacy benefit managers will not dispense a generic version of the drug to its customers, according to published reports.

November 15, 2011
Actavis launches Kadian authorized generic

Actavis has launched an authorized generic drug for treating pain, the company said.

November 15, 2011
BI announces more than $350 million in U.S. capital investments

German drug maker Boehringer Ingelheim Pharmaceuticals invested more than $350 million in its U.S. operations this year, the company said Tuesday.

November 15, 2011
GPhA urges congressional super committee not to ban patent settlements

The generic drug lobby is stepping up its efforts to persuade the congressional super committee to avoid adopting rules that would ban some patent settlements between branded and generic drug makers.

November 14, 2011
Colonial Life: Three healthcare trends that can impact retail pharmacy in 2012

Colonial Life and Accident Insurance last week released its top five trends and predictions for health care in 2012 — three of which may have some direct impact on retail pharmacy.

November 14, 2011
DSN From The Blogs: Ideas are your products, too

Ideas are just as important to a winning company’s overall success as the products and services it sells. So, what’s your company doing to create a culture where the ideas that create your products and services are as important as the products themselves?

November 14, 2011
FDA approves Qualitest painkiller

The Food and Drug Administration has approved a generic drug for treating pain.

November 11, 2011
Appeals court rejects Teva request to stop Watson from selling generic Seasonique

An appeals court has thrown out an attempt by Teva Pharmaceutical Industries to stop Watson Pharmaceuticals from selling a generic contraceptive, Watson said.

© 2013 Drug Store News. All Rights Reserved.